Form 4: Structure Therapeutics CEO Converts and Sells American Depositary Shares
SEC Form 4 Filing
Raymond C. Stevens, CEO of Structure Therapeutics Inc., converted ordinary shares into American Depositary Shares (ADS) and sold them at an average price of $52.7965.
Summary
- Raymond C. Stevens, the CEO of Structure Therapeutics Inc., converted 555,000 ordinary shares into 185,000 American Depositary Shares (ADS) on June 10, 2024.
- He then sold these 185,000 ADSs at a weighted average price of $52.7965, with prices ranging from $52.43 to $53.075.
- Following these transactions, Stevens directly owns 643,346 ordinary shares and 0 ADSs.
- He also indirectly owns 1,554,586 ordinary shares and 4,000 ADSs through the Stevens 2001 Revocable Trust.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard SEC Form 4 filing reporting a transaction. The CEO selling shares doesn't necessarily indicate a negative outlook, but it's a transaction that investors will note.
Industry Context
This filing reflects insider trading activity, which is a common occurrence for publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock and future prospects.
Stakeholder Impact
- Shareholders may react to the CEO's sale of shares, potentially influencing the stock price.
Key Dates
| Date | Description |
|---|---|
| 03/28/2001 | Date of the Stevens 2001 Revocable Trust |
| 06/10/2024 | Date of the conversion and sale of shares |
| 06/12/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.